Listed

Protalix BioTherapeutics, Inc.

PLXNYSECIK 1006281HealthcareFiscal year ends Dec 31

Reports and events: 399 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Protalix BioTherapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2019-04-1217:00 ETDEF 14AProxy statementPeriod 2019-05-300001144204-19-019545
2019-03-1809:02 ET10-KAnnual reportPeriod 2018-12-310001144204-19-014464
2019-03-1807:20 ET10-Q/AQuarterly report, amendedPeriod 2018-09-300001144204-19-014455
2019-03-1807:14 ET10-Q/AQuarterly report, amendedPeriod 2018-06-300001144204-19-014453
2019-03-1807:07 ET10-Q/AQuarterly report, amendedPeriod 2018-03-310001144204-19-014450
2019-03-1806:59 ET8-K2.02 Results of operations; 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits0001144204-19-014447
2019-02-0507:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-19-004918
2019-01-1016:05 ET8-K5.07 Shareholder vote results0001144204-19-001350
2019-01-0416:30 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-19-000672
2018-12-1707:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-18-064759
2018-12-1316:32 ET8-K5.07 Shareholder vote results0001144204-18-064451
2018-11-0716:31 ET10-QQuarterly reportPeriod 2018-09-300001144204-18-057990
2018-11-0707:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-18-057755
2018-10-1716:31 ETDEF 14AProxy statementPeriod 2018-12-130001144204-18-054229
2018-10-0507:08 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-18-052605
2018-09-2111:08 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-18-050260
2018-08-1307:10 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001144204-18-043714
2018-08-0916:09 ET10-QQuarterly reportPeriod 2018-06-300001144204-18-043286
2018-08-0907:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-18-042980
2018-07-2416:05 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-18-039629
2018-05-3116:15 ET8-K5.02 Departure or appointment of officers or directors0001144204-18-031991
2018-05-2416:05 ET8-K3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-18-030793
2018-05-1416:05 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001144204-18-028177
2018-05-0916:07 ET10-QQuarterly reportPeriod 2018-03-310001144204-18-026625
2018-05-0907:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-18-026337
2018-04-1616:06 ET8-K5.07 Shareholder vote results0001144204-18-020721
2018-03-2116:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-18-016178
2018-03-0616:11 ETDEF 14AProxy statementPeriod 2018-04-150001571049-18-000157
2018-03-0616:08 ET10-KAnnual reportPeriod 2017-12-310001144204-18-013053
2018-03-0607:46 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-18-012946
2018-01-3107:43 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-18-004740
2018-01-0516:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-18-001057
2017-12-0116:06 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001144204-17-061920
2017-11-2707:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-060846
2017-11-1307:09 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-057968
2017-11-0816:21 ET10-QQuarterly reportPeriod 2017-09-300001144204-17-057290
2017-11-0807:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-17-057015
2017-10-2009:01 ET8-K5.07 Shareholder vote results0001144204-17-053341
2017-10-1916:07 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-053226
2017-09-0116:04 ETDEF 14AProxy statementPeriod 2017-10-190001144204-17-046387
2017-08-2516:30 ETDEF 14AProxy statementPeriod 2017-10-190001144204-17-045196
2017-08-0916:18 ET10-QQuarterly reportPeriod 2017-06-300001144204-17-041693
2017-08-0907:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-17-041392
2017-07-2516:59 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-038121
2017-06-0707:37 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-031384
2017-05-1016:06 ET10-QQuarterly reportPeriod 2017-03-310001144204-17-026034
2017-05-1007:44 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-17-025800
2017-05-0907:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-025419
2017-04-1807:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-020803
2017-04-1216:05 ET8-K5.07 Shareholder vote results; 8.01 Other events0001144204-17-020173

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.